Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Yixintang Pharmaceutical Group Co., Ltd.
  6. Summary
    002727   CNE100001WJ8

YIXINTANG PHARMACEUTICAL GROUP CO., LTD.

(002727)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
01/14/2022 01/17/2022 01/18/2022 01/19/2022 01/20/2022 Date
36.51 36.15 36.35 35.79 34.45 Last
6098172 7438156 6368573 5166518 9307581 Volume
+1.25% -0.99% +0.55% -1.54% -3.74% Change
Estimated financial data (e)
Sales 2021 14 801 M 2 334 M 2 334 M
Net income 2021 1 002 M 158 M 158 M
Net cash position 2021 1 535 M 242 M 242 M
P/E ratio 2021 20,6x
Yield 2021 1,26%
Sales 2022 17 644 M 2 783 M 2 783 M
Net income 2022 1 238 M 195 M 195 M
Net cash position 2022 2 095 M 330 M 330 M
P/E ratio 2022 16,7x
Yield 2022 1,53%
Capitalization 20 538 M 3 239 M 3 239 M
EV / Sales 2021 1,28x
EV / Sales 2022 1,05x
Nbr of Employees 30 129
Free-Float 46,2%
More Financials
Company
Yixintang Pharmaceutical Group Co., Ltd., formerly Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd., is a China-based company principally engaged in the pharmaceutical chain retailing and pharmaceutical wholesaling businesses. The CompanyÔÇÖs main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The Company... 
Sector
Drug Retailers
Calendar
03/01Earnings Release
More about the company
Ratings of Yixintang Pharmaceutical Group Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
2021Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months E..
CI
2021Yixintang Pharmaceutical Co., Ltd. announced that it has received CNY 250 million in fu..
CI
2021Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year End..
CI
2021Yixintang Pharmaceutical Co., Ltd. announced that it expects to receive CNY 250 million..
CI
2021YIXINTANG PHARMACEUTICAL : Pharma to List Over 2 Million Newly Unlocked Restricted Shares
MT
2021Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter..
CI
2021Yixintang Pharmaceutical Group Co., Ltd. Approves Cash Dividend A Shares for the Year 2..
CI
2021YIXINTANG PHARMACEUTICAL : Pharma to List New Shares Issued Under Incentive Plan
MT
2021Yixintang Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2020
CI
2021Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year End..
CI
2020MARKET CHATTER : Yixintang Pharma Signs Strategic Partnership with France's Servier
MT
2020Laobaixing Reportedly in Merger Talks with Yixintang
CI
2020EXCLUSIVE : Laobaixing and Yixintang in talks to create China's largest pharmacy chain - s..
RE
2020EXCLUSIVE : Laobaixing and Yixintang in talks to create China's largest pharmacy chain - s..
RE
2020Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months E..
CI
More news
News in other languages on YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
2021Yixintang Pharma inscrit à la cote plus de 2 millions d'actions à négociation restreint..
2021Yixintang Pharmaceutical Group Co., Ltd. approuve le dividende en espèces des actions A..
2021Yixintang Pharma inscrit à la cote les nouvelles actions émises dans le cadre du plan d..
2021Yixintang Pharmaceutical Group Co., Ltd. propose un dividende final en espèces pour l'a..
2020DISCUSSIONS SUR LE MARCHÉ : Yixintang Pharma signe un partenariat stratégique avec le fran..
More news
Chart YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
Duration : Period :
Yixintang Pharmaceutical Group Co., Ltd. Technical Analysis Chart | 002727 | CNE100001WJ8 | MarketScreener
Technical analysis trends YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 34,45 CNY
Average target price 50,15 CNY
Spread / Average Target 45,6%
EPS Revisions
Managers and Directors
Hong Xian Ruan Chairman & President
Si Shun Dai Chief Financial Officer
Ping Feng Chairman-Supervisory Board
Xian Ming Yang Independent Director
Xiao Hai Long Independent Director